RISK WARNING: Your capital is at risk. The risks include: the lack of liquidity in this market in terms of being able to sell shares; the loss of the value of investment; and dilution of shareholding. When you invest any loss in value will not be covered by the Financial Services Compensation Scheme. Please read FULL risk warning.
Revolutionary molecular detection technology, which presents a unique solution to many industries including security, air pollution and healthcare.
Investment closes only once the total pledged amount passes the minimum of £500,000
A pledge is not a commitment. You will be asked to confirm in the next section.
This company has not shared it's twitter feed.
ANCON has developed and patented a disruptive technology which offers the company exciting market opportunities with the next generation of products to detect explosives, chemical weapons, narcotics and pollution in the air. The technology also has the future development potential to offer a new, non-invasive, screening and diagnostic technology, for detecting early stages of disease within the Healthcare and Veterinary sectors.